GRI Bio, Inc.
GRI
Last
$1.74
Day
+3.6%
1y
-97.0%
5y
-100.0%
52w
-97.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1333d
EMA 21
1.90
EMA 50
1.91
EMA 200
153.29
20d high
-25.3%
5y high
-100.0%
5y range
0th
Positions held
Your positionsGRI isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.94
Stop
$1.47
Stop distance
15.5%
Target vs last
+11.5%
Fundamentals
| Market cap | $3.67M | Enterprise value | -$7.23M | Trailing P/E | — | Forward P/E | -0.84 |
| PEG | — | Price / book | 0.36 | Beta | -0.61 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -142.0% | ROA | -70.9% | Debt / equity | 0.00 |
| Current ratio | 10.30 | Free cash flow | -$6.59M | Analyst recommendation | none | Mean target | $18.50 |
| 52w high | $64.12 | 52w low | $1.36 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.6M | -$2.0M | -$2.7M | -$3.4M | -$2.9M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.6M | -$2.0M | -$2.7M | -$3.4M | -$2.9M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$12.0M | -$8.2M | -$13.0M | -$3.2M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$12.0M | -$8.2M | -$11.4M | -$2.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsGRI · daily-18.0% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin